Palleon Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.palleonpharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
Phase 1
Completed
- Conditions
- Ovarian CancerCancerBreast CancerHead and Neck CancerNon Small Cell Lung CancerGastric CancerEGJEsophagogastric Junction CancerUrothelial CancerMelanoma
- Interventions
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Palleon Pharmaceuticals, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT05259696
- Locations
- 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Stanford Health Care, Stanford, California, United States
News
No news found